ELEVAR

Serial Number 88985333
Registration 7579988
700

Registration Progress

Application Filed
Aug 13, 2019
Under Examination
Jun 8, 2021
Approved for Publication
Apr 13, 2021
Published for Opposition
Apr 13, 2021
Registered
Nov 26, 2024

Trademark Image

ELEVAR

Basic Information

Serial Number
88985333
Registration Number
7579988
Filing Date
August 13, 2019
Registration Date
November 26, 2024
Published for Opposition
April 13, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 26, 2024
Registration
Registered
Classes
044

Rights Holder

Elevar Therapeutics, Inc.

03
Address
2825 East Cottonwood Parkway, Suite 180
Salt Lake City, UT 84121

Ownership History

Elevar Therapeutics, Inc.

Original Applicant
03
Salt Lake City, UT

Elevar Therapeutics, Inc.

Owner at Publication
03
Salt Lake City, UT

Elevar Therapeutics, Inc.

Original Registrant
03
Salt Lake City, UT

Legal Representation

Attorney
Cynthia Johnson Walden

USPTO Deadlines

Next Deadline
1798 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241126)
Due Date
November 26, 2030
Grace Period Ends
May 26, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Nov 26, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 26, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 16, 2024 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Feb 16, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 15, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 11, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 8, 2023 IUAF S USE AMENDMENT FILED Loading...
Dec 11, 2023 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Dec 8, 2023 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Dec 8, 2023 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Dec 8, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 10, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 8, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 8, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 8, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 7, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 7, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 7, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 10, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 8, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 8, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 8, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 15, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 8, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 15, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 8, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 8, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 8, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 8, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 8, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 8, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 10, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 8, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 8, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 8, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 8, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 13, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 13, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 10, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 10, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 9, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 9, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 20, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 20, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Aug 20, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 16, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jun 16, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Jun 16, 2020 CNFR R FINAL REFUSAL WRITTEN Loading...

Detailed Classifications

Class 044
Research and development of experimental and novel cancer therapeutics prescribed by medical professionals and distributed to medical professionals and not directed to retail pharmacies and not directed to patients
First Use Anywhere: Oct 16, 2019
First Use in Commerce: Oct 16, 2019

Additional Information

Translation
The English translation of "ELEVAR" in the mark is "to raise".

Classification

International Classes
044